Latest news and articles about clinical trials from NEX English
Saudi Arabia announced a rise in average life expectancy from 74 years in 2016 to 79.9 years by the end of 2025, attributed to the health sector transformation program. This improvement is linked to a significant increase in clinical trials, which saw a 51.4% rise between 2023 and 2025.
The Saudi Health Sector Transformation Program has announced significant achievements in the healthcare system, raising the average life expectancy from <strong>74 years</strong> in 2016 to <strong>79.9 years</strong> by the end of 2025, bringing the Kingdom closer to its Vision 2030 goals.
Blockstone has announced the closure of its latest life sciences fund, raising a total of <strong>$6.3 billion</strong>. This significant amount marks the largest fundraising effort by the company to support clinical trials for drugs and technologies in a time of increasing investments in the healthcare sector.
The CEO of Apyvax stated that the company is not in a hurry to sell itself, planning to raise funds after releasing critical trial data in June. This comes amid strong rumors of a potential acquisition by major pharmaceutical companies.
Pfizer, in collaboration with French partner Valneva, announced its intention to seek regulatory approval for a Lyme disease vaccine after successful advanced clinical trials. This initiative comes amid growing interest in new methods to combat this globally significant health threat.